This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NovoLog 100 unit/mL insulin vials. The $1,005.72 firm fixed-price contract has a period of performance through November 14, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These strategic contract vehicles enable efficient government procurement of essential pharmaceutical and medical items to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/12/25, 9:26 AM